Cytokine-Induced Killer Cells Express CD39, CD38, CD203a, CD73 Ectoenzymes and P1 Adenosinergic Receptors-Reference-Cited by-同舟云学术

Cytokine-Induced Killer Cells Express CD39, CD38, CD203a, CD73 Ectoenzymes and P1 Adenosinergic Receptors

Published:2018-04-20 Issue: Volume:9 Page:
ISSN:1663-9812
Container-title:Frontiers in Pharmacology
language:
Short-container-title:Front. Pharmacol.

Author:

Horenstein Alberto L.,Chillemi Antonella,Zini Roberta,Quarona Valeria,Bianchi Nicoletta,Manfredini Rossella,Gambari Roberto,Malavasi Fabio,Ferrari Davide

Publisher

Frontiers Media SA

Subject

Pharmacology (medical),Pharmacology

Reference66 articles.

1. Immunosuppressive activities of adenosine in cancer;Allard;Curr. Opin. Pharmacol.,2016

2. Targeting A2 adenosine receptors in cancer;Allard;Immunol. Cell Biol,2017

3. Anti-CD73 immunotherapy: a viable way to reprogram the tumor microenvironment;Antonioli;Oncoimmunology

4. Anti-CD73 in cancer immunotherapy: awakening new opportunities;Antonioli;Trends Cancer.

5. Th17 cells in cancer: the ultimate identity crisis;Bailey;Front. Immunol.,2014

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Purification and analysis of kidney-infiltrating leukocytes in a mouse model of lupus nephritis;Methods in Cell Biology;2024

2. CD39 abrogates platelet-derived factors induced IL-1β expression in the human placenta;Frontiers in Cell and Developmental Biology;2023-05-30

3. Improving combination therapies: targeting A2B-adenosine receptor to modulate metabolic tumor microenvironment and immunosuppression;JNCI: Journal of the National Cancer Institute;2023-05-17

4. NK cell immunometabolism as target for liver cancer therapy;International Immunopharmacology;2022-11

5. Adenosine signaling: Optimal target for gastric cancer immunotherapy;Frontiers in Immunology;2022-09-16